Immunotherapy
Research reports on immunotherapy from University of Chicago, Department of Surgery provide new insights
Published in Drug Week, April 27th, 2007
New research, "Recognition of carcinoembryonic antigen peptide and heteroclitic peptide by peripheral blood T lymphocytes," is the subject of a report. According to recent research from the United States, "The carcinoembryonic antigen (CEA)-derived peptide CAP1 and heteroclitic peptide CAP1-6D are stimulators of HLA-A*A0201 restricted CEA-specific T cells in vivo and in vitro. The goal of this study was to evaluate differences in T cell responses to peptide and modified peptide antigens from CEA."
"The heterogeneity of responses among individuals is potentially important for the design of future CEA-directed immunotherapy trials. Peripheral blood mononuclear cells from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-04-27)
More Articles from Drug Week
- Asthma
Living Well: Health and Wellness Tips from Indiana University - Atrial Fibrillation
Use of hydrocortisone reduces incidence of atrial fibrillation after cardiac surgery - Bipolar Disorders
Lithium Builds Gray Matter in Bipolar Brains - Breast Cancer
Jefferson scientists identify protein key to breast cancer spread, potential new drug target - Cancer
Can Science Stop Cancer Before It Starts? - Cancer
Massive gene screening points way to more effective chemotherapy - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
